Sample size for Pivotal Partial Replicate desing [Power / Sample Size]

posted by Nirav Jani – 2011-02-03 20:32 (5622 d 21:47 ago) – Posting: # 6550
Views: 7,188

Dear All,

We have pilot data for partial reference replicate design (2 treatment, 3 period reference replicate design).

Based on pilot results for N=9 subjects, intra-subject cv of Cmax and AUC for reference product is 28% and 25%, respectively. The ratio (T/R) for Cmax and AUC is 115% and 114%, respectively. The power of the study for Cmax and AUC is below 70%.

It will be helpful if someone suggest me for the sample size calculation for pivotal partial replicated design (2 treatment, 3 period reference replicate design) using the above information?

Thanks and regards,
Nirav Jani

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
363 visitors (0 registered, 363 guests [including 16 identified bots]).
Forum time: 19:19 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5